chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child diagnosed with appendicitis.; This is a spontaneous report from a contactable consumer (patient). A 15 years-old male patient received 2nd dose of covid vaccine lot number=EW0180, at the age of 15 years old, on 08Jun2021 04:00 PM on Left arm for covid-19 immunization. No known allergy. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination was multivitamin. Historical vaccine was the 1st dose of BNT162B2 (lot number=EW0177) on 18May2021 04:00 PM on Left arm for covid-19 immunization. No reaction on previous exposure to vaccine. On 14Jun2021 11:00 PM, Child diagnosed with appendicitis. AE resulted in Emergency room/department or urgent care, Hospitalization 1 day. Treatment was Appendectomy. Seriousness criteria-Caused/prolonged hospitalization. Prior to vaccination, patient was not diagnosed with COVID-19. Covid test post vaccination: covid test type post vaccination=Blood test on 15Jun2021, Negative. Outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Covid; This is a spontaneous report from a Pfizer-sponsored program Pfizer . A contactable consumer reported that a female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, developed Covid within a week after Frist Vaccine. How long do they have to wait to get second dose. The outcome of event was unknown.  Information on the lot/batch number has been requested.
injection site itchy; rounf red circle at the injection site(2 inch diameter); Injection site getting sore again; Sore arm at injection site; Headache; Some fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache), FATIGUE (Some fatigue), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache) and FATIGUE (Some fatigue). On 12-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) and INJECTION SITE PAIN (Injection site getting sore again). On 10-Jan-2021, VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache) and FATIGUE (Some fatigue) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) and INJECTION SITE PAIN (Injection site getting sore again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On March 27th, I start having signs of a UTI-urinary tract infection. I suffered thru them until Thursday. I went to see the doctor on the 30th. He did a CBC and Urinalysis. I was diagnosed with a urinary tract infection. I was prescribed MACROBID antibiotics. I took them twice a day for 10 days. My symptoms finally seem to have resolved today.
12-15: Headache, lower back pain, nausea, swelling of right arm. 12-16: Headache, back pain, nausea, dizziness, hot/cold body symptoms, exhaustion. Approx. 6-8 size redness of injection site. Started TYLENOL and BENADRYL per Dr. orders. 12-17: still continue on TYLENOL and BENADRYL. Developed rash on face-all over-red, also rash over redness on arm of injection site. Included all of the following wk. until Dec 21, 17. I felt tired and arm took all this week at least to get the inflammation out. The sickest week I have felt in a lot of years and I am 65.
Administered 0.5ml dose of Pfizer booster to the patient instead of the indicated 0.3mL dose. Minor and expected side effects noted. No residual symptoms.
My husband  had flu shot, 9 hours later we had severe vomiting and Diarrhea that lasted into the early morning hours.
Client reported pain on right trunk.  Vaccine administered 10 days previous Sub Q, in Right Arm.  4/14/2011 pt went to see PCP due to formation of rash and fluid filled vesicle on Right shoulder blade.  PCP diagnosed as shingles.  Pt is now undergoing treatment.
Immediate syncope lasting about 15 seconds with 5 seconds of tonic-clonic activity and brief emesis. Normal mental status within 30 seconds. Initial heart rate 50, and BP 90/60, recovered to normal with BP 100/60 and heart rate 70 within 30 minutes. No signs of allergic reaction or anaphylaxis. Taking fluids and felt well upon discharge.
Vaccine:  Smallpox (Vaccinia) 7 days after primary vaccination developed pruritic maculopapular rash on trunk with later spread to extremities.  Patient was well appearing and felt well except for pruritis.  No mucous membrane involvement.  No underlying medical conditions.  Pt diagnosed with GV and treated with antihistamines and NSAIDS.  Contact precautions given.
Rash covering both arms; This is a spontaneous report from a non-contactable nurse. A 24-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 31Mar2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 01Apr2021, next day after the first dose, the patient experienced rash covering both the arms. Therapeutic measures were taken as a result of the event and included treatment with hydrocortisone cream and ice packs. The clinical outcome of the event rash covering both arms was resolved on 02Apr2021.  No follow-up attempts are possible. No further information is expected.
Rash developed, painful and swollen left arm from subq. injection of SHINGRIX.
Presented with SOB/hypoxia; Dx with Covid 7 days PTA; previously treated with antibiotics but developed worsening hypoxia; CXR: patchy bilat lung infiltrates; Tx: Zithromax, Rocephin, Decadron, Remdesivir, Vit C, Lovenox,; airvo and Bipap for supplemental O2Patient's respiratory status continued to worsen requiring high-flow oxygen.  In view of worsening respiratory status, and patient was a DNR , discussed with daughter who did not want ot pursue aggressive treatment and requested to be placed on comfort measures only. Transferred to General inpatient hospice . Pt died on 1/25/22
May be the needle he got did not have enough solution in it; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (May be the needle he got did not have enough solution in it) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced ACCIDENTAL UNDERDOSE (May be the needle he got did not have enough solution in it). At the time of the report, ACCIDENTAL UNDERDOSE (May be the needle he got did not have enough solution in it) outcome was unknown.            No concomitant medications was reported   No treatment medications was provided   The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.   This case was linked to MOD-2021-122406 (Patient Link).
Patient with past medical history significant for thyroid cancer was given  Pfizer COVID-19 vaccine at approximately 1430 at our facility. After receiving vaccine patient felt flushed, face hot, felt something squeezing neck (similar to tight collar). 25 mg PO diphenhydramine given X 1. Patient having shivering on and off. Felt swelling progress up into back of throat. Had to clear throat and swallow harder. At 1511 patient was checked into the emergency department at our hospital. At 1527 famotidine 20 mg IV once given. BP was found to be 232/100. Amlodipine 5 mg IV once given at 1909. Labetalol 10 mg IV once given at 1812, labetalol 20 mg IV once given at 2034, clonidine 0.1 mg PO once given at 2127. Patient sent home at approximately midnight. Diagnosed with possible anaphylaxis and hypertensive urgency (no history of HTN).
My daughter had blood work (for cholesterol check due to weight following her vaccine). Her platelet levels were very low and she has since been diagnosed with ITP. This has never before been a problem. Additionally she has, since her vaccine, been complaining of odd muscular aches, pains, weakness, and spasms. Again, something that has never occurred before. We are in the process of trying to get to the bottom of all of this.
After I got the shot I went home, ate dinner, and went to bed. I woke up around 2 AM with extreme period cramping and bleeding. Before the shot, I have not had my period in 5 years. I have had intense cramping and bleeding for the past couple of days. I am still experiencing it and I am submitting this on April 23rd 2021.
Received DTaP and Comvax in right arm, MMR in left arm at 1:30pm. Within 1 hr right arm was swollen, red, bruised which continued to worsen x 2 days. Fever started within 2 hrs after immunizations 101-104 by evening. Fever continued to increase 104.5 through 06/07/02 despite Motrin. Seen by Dr on 06/06/02 dx. DTaP reaction, given Benadryl and Motrin.
About a week after receiving the Pfizer vaccine, it was my first time. I usually get Moderna, I had severe vertigo and felt sick for a month. I had more joint pain than normal in my knees and lower legs.  I had leg weakness and fatigue. Rest helped and it just kept coming back. The vertigo I went in the end of November, and I was sent to physical therapy, but I still was having joint pain and low-grade fevers and go and come back for a few days. The day after Christmas I had sever joint point and tingling down my legs and extreme joint pain. I felt as if I was recovering from Mono.  I went to my doctor, and I was put on Sim Valta, it helped tremendously.
26 Patient received a expired vaccine 16 Apr 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (26 Patient received a expired vaccine 16 Apr 2022) in a 50-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (26 Patient received a expired vaccine 16 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (26 Patient received a expired vaccine 16 Apr 2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter.  No allergy was reported by reporter.  Patient was never diagnosed with COVID-19.  No treatment medication reported by reporter.
Congestion in left ear.  Noticeable decrease in hearing in left ear that has persisted until today 4/16/21.
Patient report slight cough with hives noted on arm, hands, trunk, and back of neck. Over the counter Benadryl taken self administered at 2;20 pm observed by nursing staff. Hives resolved at 2:45 and patient released to self care.
Patient states it hurt was red and swollen about 3x4 inches, began about 2 days after vaccine administered. She said it did get worse after 72 hours. Once told by pharmacist to use Benadryl and ice packs, the situation began to resolve and she is feeling much better. Dr. never returned her call.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue) and MYALGIA (Bad body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR), TRIAMCINOLONE ACETONIDE (NASACORT), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), SALBUTAMOL (ALBUTEROL HFA), COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECARENONE;ZINC OXIDE] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue), MYALGIA (Bad body aches), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), FATIGUE (Fatigue), MYALGIA (Bad body aches) and CHILLS (Chills) had not resolved and ERUCTATION (Burping), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included Tylenol 500 mg.
Light headiness, achy, Nausea, Severe headache, BP dropped, Hot/Cold chills.  Clammy/Pale.    Pt was sent home unable to function due to light headiness and nausea. Unable to walk due to unsteadiness.
developed nodularities on the extensor sufaces of hand, upper extremities, feet and face.; This case was reported by a physician via call center representative and described the occurrence of nodule on extremity in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. In March 2020, 2 days after receiving Shingrix, the patient experienced nodule on extremity. On an unknown date, the outcome of the nodule on extremity was unknown.   It was unknown if the reporter considered the nodule on extremity to be related to Shingrix.  Additional details were provided as follows: The patient had her first dose nine days ago. Seven days ago she developed nodularities on the extensor sufaces of hand, upper extremities, feet and face. Mouth was clear. He was not sure if it is hand, foot and mouth disease. The physician was in a hurry and did not have time to answer all questions. Did not have the lot number. Consented to follow up.
5 year minimum intervals between first PPSV23 and 2nd PPSV23 not met
This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAPULE (Progressively worsened into "red bump" and "hives"), VACCINATION SITE PRURITUS (Itching initially at the site of the injection), VACCINATION SITE URTICARIA (Progressively worsened into "red bump" and "hives") and VACCINATION SITE ERYTHEMA (Redness initially at the site of the injection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history provided by reporter. Concurrent medical conditions included Allergy to antibiotic (Allergies to Amoxicillin), Drug allergy (Allergies to Statins) and Drug allergy (Allergies to percocet). On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching initially at the site of the injection) and VACCINATION SITE ERYTHEMA (Redness initially at the site of the injection). On 07-Mar-2021, the patient experienced VACCINATION SITE PAPULE (Progressively worsened into "red bump" and "hives") and VACCINATION SITE URTICARIA (Progressively worsened into "red bump" and "hives"). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Antihistamine therapy, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Antihistamine therapy, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAPULE (Progressively worsened into "red bump" and "hives"), VACCINATION SITE PRURITUS (Itching initially at the site of the injection), VACCINATION SITE URTICARIA (Progressively worsened into "red bump" and "hives") and VACCINATION SITE ERYTHEMA (Redness initially at the site of the injection) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product used was not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Died within 24hr of vaccine. Found dead in crib (poss SIDS). Medical examiner report pending.
throat numb; throat tingly; mouth numb; mouth tingly; arm very warm to touch; arm swollen up; arm very red; This spontaneous case was reported by an other health care professional and describes the occurrence of PHARYNGEAL HYPOAESTHESIA (throat numb), OROPHARYNGEAL DISCOMFORT (throat tingly), HYPOAESTHESIA ORAL (mouth numb), STOMATITIS (mouth tingly) and VACCINATION SITE WARMTH (arm very warm to touch) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HCTZ, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and ESTRADIOL (VIVELLE [ESTRADIOL]) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PHARYNGEAL HYPOAESTHESIA (throat numb), OROPHARYNGEAL DISCOMFORT (throat tingly), HYPOAESTHESIA ORAL (mouth numb), STOMATITIS (mouth tingly), VACCINATION SITE WARMTH (arm very warm to touch), VACCINATION SITE SWELLING (arm swollen up) and VACCINATION SITE ERYTHEMA (arm very red). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing from 20-Jan-2021 at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 20-Jan-2021 to 22-Jan-2021 for Numbness, at a dose of 25 mg. On 24-Jan-2021, PHARYNGEAL HYPOAESTHESIA (throat numb), OROPHARYNGEAL DISCOMFORT (throat tingly), HYPOAESTHESIA ORAL (mouth numb), STOMATITIS (mouth tingly), VACCINATION SITE WARMTH (arm very warm to touch), VACCINATION SITE SWELLING (arm swollen up) and VACCINATION SITE ERYTHEMA (arm very red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 20 Jan 2021, the patient reported her arm started to swell and she has numbness and tingling in her mouth, neck and throat.  On 24 Jan 2021 she recovered from the events of  swelling, numbness and tingling in her mouth, neck and throat .   This case was linked to MOD-2021-237552.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up information received on 25 JUN 2021, updated patient demography and concomitant medications.
Patient was administered a pfizer, maroon cap covid-19 vaccine (6 mo-4 years). The medical assistant preparing the vaccine diluted  the vaccine with an incorrect amount of sodium chloride. She diluted with 1.3 ml instead of 2.2 ml of sodium chloride. No adverse reaction has been reported to us by this family. We did notify family of the error.
I had lots of coughing and a fever. I had headache and severe fatigue. I also had leg aches and pain. These lasted for about 2 or 3 days. I went to the doctor about this. They gave me steroids and antibiotics. They say that I got pneumonia. They also did COVID-19 test, negative results.
Woke up this morning with a rash on my upper left arm, just below the injection site, itchy and slightly warm to the touch
Received Meningitis vaccine instead of TDap. First meningitis vaccine received 03/2022.
itchiness and redness at the injection site; itchiness and redness at the injection site; This is a spontaneous report received from a contactable reporter (Other HCP) from the Medical Information Team.  A patient (no qualifiers provided) received respiratory syncytial virus vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (batch/lot number: unknown) for immunization; for immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PRURITUS (non-serious), VACCINATION SITE ERYTHEMA (non-serious), outcome "recovering" and all described as "itchiness and redness at the injection site." Therapeutic measures were taken as a result of vaccination site pruritus, vaccination site erythema.  Additional information: The caller reported an adverse reaction experienced by a patient from Abrysvo Respiratory Syncytial Virus Vaccine which was itchiness and redness at the injection site which was intense for the 1st 24 hours and became less intense after Benadryl. Caller asked if there are any available educational material that can be sent to them for patients to see.  The information on the batch/lot number for respiratory syncytial virus vaccine prot.subunit pref 2v, respiratory syncytial virus vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
Shortness of breath, cyanotic- Epinephrine and Benadryl administered
t105.7 approx 1 1/2hr p/vax in rt medial lateral thigh;given APAP @ home & brought back to clinic by mom;